Vectin Horse Paste Data Sheet

Presentation

A yellow, gel-like paste of uniform consistency, containing:

Active Substances

Ivermectin                                 18.7 mg/g          Active

Excipient:

Apple Flavour                           20 mg/g             Flavouring

Uses

Vectin^® Horse Paste is indicated for the treatment of nematode or arthropod infestations in horses due to:

Large strongyles

S. vulgaris   (adults and fourth larval [arterial] stages)

             S. edentatus   (adults and fourth larval [tissue] stages)

             S. equinus(adults)

Triodontophorusspp. (adults) 

            T. brevicauda

             T. serratus

Small Strongyles        

Adults and immatures (fourth stage larvae) small strongyles or cyathostomes unless otherwise stated. Ivermectin is not effective against the encysted larval stages of the small strongyles. 

Coronocyclusspp.

 C. coronatus

             C. labiatus

             C. labratus

Cyathostomumspp.

    C. catinatum

    C. pateratum

Cylicocyclusspp.

             C. ashworthi

             C. elongatus

             C. insigne

             C. leptostomum

             C. nassatus

Cylicostephanus  spp.

             C. calicatus

             C. goldi

             C. longibursatus

             C. minutus

Cylicodontophorusspp.

            C. bicornatus

Parapoteriostomumspp.

            P. mettami

Petrovinemaspp.

            P. poculatum

Poteriostomumspp.

Lungworms  (adult and inhibited fourth stage larvae)

Dictyocaulus arnfieldi

Pinworms  (adult and inhibited fourth stage larvae)

Oxyuris equi

Ascarids  (adults and third & fourth stage larvae)

Parascaris equorum

Hairworms  (adults)

Trichostrongylus axei

Large-mouth stomach worms  (adults)
Habronema muscae

Neck threadworms  (microfilariae)

Onchocercaspp.

Intestinal threadworms  (adults)

Strongyloides westeri

Stomach bots (oral and gastric stages)

Gasterophilusspp.

Dosage and administration

Administer orally as a single dose rate to horses at the recommended dose level of 0.2 mg ivermectin per kilogram of bodyweight.   Each syringe delivers 120 mg ivermectin, sufficient to treat 600 kg of bodyweight.

Single administration. Bodyweight and dosage should be accurately determined prior to treatment.

Dosing Instructions

Each weight-marking on the syringe plunger will deliver sufficient paste to treat 100kg bodyweight.   Unlock the knurled ring by making ¼ turn and slide the knurled ring up the plunger shaft so that the side nearest the barrel is at the prescribed weight marking.   Turn the knurled ring ¼ turn to lock in place.   Make sure the horse’s mouth contains no feed. Remove the plastic cap from the tip of the nozzle.  

Insert the syringe into the horse’s mouth at the interdental space.   Advance the plunger as far as it will go, depositing the medication on the base of the tongue.   Immediately raise the horse’s head for a few seconds after dosing.

The treatment schedule should be based on the local epidemiological situation. 

Contra-indications, warnings, etc.

Do not use in mares producing milk for human consumption.

Some horses carrying heavy infestation of Onchocerca  microfilariae have experienced oedema and pruritus following dosing, assumed to be the result of death of large numbers of microfilariae.   These signs resolve within a few days but symptomatic treatment may be advisable.

Special warning for non-target species: The product has been formulated for use in horses only.   Cats, Dogs, especially Collies, Old English Sheepdogs and related breeds or crosses, and also turtles and tortoises may be adversely affected by the concentration of ivermectin in this product if they are allowed to ingest spilled paste or have access to used syringes.

As ivermectin is extremely dangerous to fish and aquatic life, treated animals should not have direct access to surface waters and ditches during treatment.

Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

Studies performed in laboratory animals showed no teratogenic or embryotoxic effect of ivermectin at the recommended doses during therapy.

The safety of the veterinary medicinal product has not been established during pregnancy and lactation.   Use only according to risk/benefit analysis by the responsible veterinary surgeon.

Do not eat, drink or smoke while handling the product. Avoid contact with skin and eyes. If accidental skin contact occurs, wash the affected area immediately with soap and water. If accidental eye exposure occurs, flush the eyes immediately with water and if necessary get medical attention.

Wash hands after use.

Withdrawal period:

Meat and offal - 34 days.

Do not use in mares producing milk for human consumption.

FOR ANIMAL TREATMENT ONLY. 

KEEP OUT OF REACH AND SIGHT OF CHILDREN.

Pharmaceutical precautions

No special precautions for storage.

This is a single dose product. Discard after use.

Environmental warnings:

EXREMELY DANGEROUS TO FISH AND AQUATIC LIFE. 

Do not contaminate surface waters or ditches with product or used containers.  

Any unused product or waste material should be disposed of in accordance with national requirements. 

Legal category

PML      To be supplied only on veterinary prescription.

Package quantities

High density polyethylene pre-filled dose-graduated disposable syringe containing 6.42 g of product.

Further information 

Nil.

Marketing Authorisation number

Vm 12597/4031

Distributed by:

Intervet UK Ltd.,

Walton Manor, Walton.

Milton Keynes.

Bucks.

MK7 7AJ

Date of text preparation: 

October 2006.

                                                                                                             75115^.Oct06/MP